PROCESSA PHARMACEUTICALS INC (PCSA) Stock News

NASDAQ:PCSA - Nasdaq - US74275C3043 - Common Stock - Currency: USD

0.23 +0.01 (+4.55%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

PCSA Latest News, Press Relases and Analysis

All

Press Releases

6 days ago - By: Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies

6 days ago - By: Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies

a month ago - By: ACCESS Newswire - Mentions: BFRG

Processa Pharmaceuticals and BullFrog AI Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

2 months ago - By: Benzinga - Mentions: SEDG RUN ACXP CERO ...

US Stocks Lower; Retail Sales Decline In May

a month ago - By: Yahoo Finance

Processa Pharmaceuticals, Inc. (PCSA) Secures Buy Rating on Portfolio Progress

2 months ago - By: Benzinga - Mentions: EXEL LUCY IBO SSII ...

12 Health Care Stocks Moving In Monday's Pre-Market Session

2 months ago - By: Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering

2 months ago - By: Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate

2 months ago - By: Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025

3 months ago - By: Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting

5 months ago - By: Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference

6 months ago - By: Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference